Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Cumberland Pharmaceuticals (CPIX) Other Gross PP&E Adjustments (2016 - 2026)

Cumberland Pharmaceuticals' Other Gross PP&E Adjustments history spans 15 years, with the latest figure at -$5.7 million for Q4 2025.

  • On a quarterly basis, Other Gross PP&E Adjustments fell 58.23% to -$5.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$5.7 million, a 58.23% decrease, with the full-year FY2025 number at -$5.7 million, down 58.23% from a year prior.
  • Other Gross PP&E Adjustments hit -$5.7 million in Q4 2025 for Cumberland Pharmaceuticals, up from -$7.6 million in the prior quarter.
  • Over the last five years, Other Gross PP&E Adjustments for CPIX hit a ceiling of $2.4 million in Q4 2021 and a floor of -$7.6 million in Q3 2025.
  • Historically, Other Gross PP&E Adjustments has averaged -$4.0 million across 5 years, with a median of -$4.6 million in 2023.
  • Biggest five-year swings in Other Gross PP&E Adjustments: soared 102.35% in 2021 and later tumbled 2952.61% in 2023.
  • Tracing CPIX's Other Gross PP&E Adjustments over 5 years: stood at $2.4 million in 2021, then plummeted by 246.65% to -$3.5 million in 2022, then dropped by 21.81% to -$4.2 million in 2023, then grew by 15.49% to -$3.6 million in 2024, then crashed by 58.23% to -$5.7 million in 2025.
  • Business Quant data shows Other Gross PP&E Adjustments for CPIX at -$5.7 million in Q4 2025, -$7.6 million in Q3 2025, and -$7.1 million in Q2 2025.